Combined H1 and H2 receptor blockade attenuates the cardiovascular effects of high dose atracurium in rabbits

Michael Hosking, Robert L. Lennon, Gerald A. Gronert

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

Large doses of atracurium (1.5 mg/kg) (six times the ED95) have been reported to provide adequate conditions for rapid sequence endotracheal intubation within 60 seconds in humans. However, this dose can result in significant histamine release and systemic hypotension. We therefore studied the efficacy of histamine receptor blockade in attenuating this response. Four groups of five rabbits were pretreated as follows: Group I - control, Group II - H1 blockade (1 mg/kg diphenhydramine), Group III -H2 blockade (cimetidine 4 mg/kg), and Group IV - H1 and H2 blockade (diphenhydramine 1 mg/kg and cimetidine 4 mg/kg). All rabbits were anesthetized and then 1.8 mg/kg (six times the rabbit ED95) atracurium was administered. Group I rabbits experienced a decrease in MAP of 12.2 mmHg after one minute, a change that was significantly greater than Group IV in which MAP decreased by 0.8 mmHg (p < 0.001). H1 or H2 receptor blockade alone was associated with intermediate changes in MAP not significantly different from control. We conclude that combined H1 and H2 receptor blockade attenuates the cardiovascular effects associated with large doses of atracurium in the rabbit and that this combination of antagonist drugs might have similar effectiveness in humans.

Original languageEnglish (US)
Pages (from-to)347-353
Number of pages7
JournalLife Sciences
Volume44
Issue number5
DOIs
StatePublished - Jan 1 1989

Fingerprint

Atracurium
Histamine H1 Receptors
Histamine H2 Receptors
Diphenhydramine
Cimetidine
Rabbits
Histamine Receptors
Histamine
Intratracheal Intubation
Histamine Release
Drug Combinations
Hypotension
Pharmaceutical Preparations
Control Groups

All Science Journal Classification (ASJC) codes

  • Biochemistry, Genetics and Molecular Biology(all)
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Combined H1 and H2 receptor blockade attenuates the cardiovascular effects of high dose atracurium in rabbits. / Hosking, Michael; Lennon, Robert L.; Gronert, Gerald A.

In: Life Sciences, Vol. 44, No. 5, 01.01.1989, p. 347-353.

Research output: Contribution to journalArticle

@article{8759da06d19447fbb1dee6bde55bd5bb,
title = "Combined H1 and H2 receptor blockade attenuates the cardiovascular effects of high dose atracurium in rabbits",
abstract = "Large doses of atracurium (1.5 mg/kg) (six times the ED95) have been reported to provide adequate conditions for rapid sequence endotracheal intubation within 60 seconds in humans. However, this dose can result in significant histamine release and systemic hypotension. We therefore studied the efficacy of histamine receptor blockade in attenuating this response. Four groups of five rabbits were pretreated as follows: Group I - control, Group II - H1 blockade (1 mg/kg diphenhydramine), Group III -H2 blockade (cimetidine 4 mg/kg), and Group IV - H1 and H2 blockade (diphenhydramine 1 mg/kg and cimetidine 4 mg/kg). All rabbits were anesthetized and then 1.8 mg/kg (six times the rabbit ED95) atracurium was administered. Group I rabbits experienced a decrease in MAP of 12.2 mmHg after one minute, a change that was significantly greater than Group IV in which MAP decreased by 0.8 mmHg (p < 0.001). H1 or H2 receptor blockade alone was associated with intermediate changes in MAP not significantly different from control. We conclude that combined H1 and H2 receptor blockade attenuates the cardiovascular effects associated with large doses of atracurium in the rabbit and that this combination of antagonist drugs might have similar effectiveness in humans.",
author = "Michael Hosking and Lennon, {Robert L.} and Gronert, {Gerald A.}",
year = "1989",
month = "1",
day = "1",
doi = "10.1016/0024-3205(89)90228-2",
language = "English (US)",
volume = "44",
pages = "347--353",
journal = "Life Sciences",
issn = "0024-3205",
publisher = "Elsevier Inc.",
number = "5",

}

TY - JOUR

T1 - Combined H1 and H2 receptor blockade attenuates the cardiovascular effects of high dose atracurium in rabbits

AU - Hosking, Michael

AU - Lennon, Robert L.

AU - Gronert, Gerald A.

PY - 1989/1/1

Y1 - 1989/1/1

N2 - Large doses of atracurium (1.5 mg/kg) (six times the ED95) have been reported to provide adequate conditions for rapid sequence endotracheal intubation within 60 seconds in humans. However, this dose can result in significant histamine release and systemic hypotension. We therefore studied the efficacy of histamine receptor blockade in attenuating this response. Four groups of five rabbits were pretreated as follows: Group I - control, Group II - H1 blockade (1 mg/kg diphenhydramine), Group III -H2 blockade (cimetidine 4 mg/kg), and Group IV - H1 and H2 blockade (diphenhydramine 1 mg/kg and cimetidine 4 mg/kg). All rabbits were anesthetized and then 1.8 mg/kg (six times the rabbit ED95) atracurium was administered. Group I rabbits experienced a decrease in MAP of 12.2 mmHg after one minute, a change that was significantly greater than Group IV in which MAP decreased by 0.8 mmHg (p < 0.001). H1 or H2 receptor blockade alone was associated with intermediate changes in MAP not significantly different from control. We conclude that combined H1 and H2 receptor blockade attenuates the cardiovascular effects associated with large doses of atracurium in the rabbit and that this combination of antagonist drugs might have similar effectiveness in humans.

AB - Large doses of atracurium (1.5 mg/kg) (six times the ED95) have been reported to provide adequate conditions for rapid sequence endotracheal intubation within 60 seconds in humans. However, this dose can result in significant histamine release and systemic hypotension. We therefore studied the efficacy of histamine receptor blockade in attenuating this response. Four groups of five rabbits were pretreated as follows: Group I - control, Group II - H1 blockade (1 mg/kg diphenhydramine), Group III -H2 blockade (cimetidine 4 mg/kg), and Group IV - H1 and H2 blockade (diphenhydramine 1 mg/kg and cimetidine 4 mg/kg). All rabbits were anesthetized and then 1.8 mg/kg (six times the rabbit ED95) atracurium was administered. Group I rabbits experienced a decrease in MAP of 12.2 mmHg after one minute, a change that was significantly greater than Group IV in which MAP decreased by 0.8 mmHg (p < 0.001). H1 or H2 receptor blockade alone was associated with intermediate changes in MAP not significantly different from control. We conclude that combined H1 and H2 receptor blockade attenuates the cardiovascular effects associated with large doses of atracurium in the rabbit and that this combination of antagonist drugs might have similar effectiveness in humans.

UR - http://www.scopus.com/inward/record.url?scp=0024477114&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0024477114&partnerID=8YFLogxK

U2 - 10.1016/0024-3205(89)90228-2

DO - 10.1016/0024-3205(89)90228-2

M3 - Article

VL - 44

SP - 347

EP - 353

JO - Life Sciences

JF - Life Sciences

SN - 0024-3205

IS - 5

ER -